We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) said Dec. 12 it had commissioned a research program to learn more about how healthcare professionals and the public view the risks and benefits associated with medical devices, drugs and supplies.
The largest-ever study of carotid stenting in high-risk surgical patients found that community physicians are just as successful at using catheter-based techniques to unclog carotid arteries (arteries in the neck that supply blood to the brain) as those who pioneered the procedure at major university medical centers, the Society for Cardiovascular Angiography and Interventions (SCAI) announced Dec. 14.
Economic growth and a desire to improve the overall quality of and access to healthcare services should make Latin America an enticing market for medical device manufacturers.
Lombard Medical Technologies announced Monday that it is temporarily suspending European clinical procedures involving its Generation II Aorfix endovascular stent graft following the discovery of a problem with the placement of the graft in a small number of patients.
As information technology (IT) becomes integral in medical device design, clinical and IT specialists need better communication during the earliest stages of device development, experts said at a recent audioconference hosted by healthcare research group ECRI.
VisEn Medical announced Monday that it has signed an exclusive distribution agreement with Olympus covering sales of the company's fluorescence molecular tomography (FMT) imaging systems and portfolio of in vivo near infrared fluorescence imaging probes in Asia (South Korea, Singapore, China and Taiwan).
There is currently no evidence of increased rates of death or heart attack from drug-eluting stents versus bare-metal stents, but more trials with consistent protocols are needed to adequately assess the risk, an FDA panel concluded Dec. 7.
Sens. Chris Dodd (D-Conn.) and Mike DeWine (R-Ohio) introduced a bill to promote the development and use of medical devices designed for young children so physicians have choices over "one-size-fits-all" products.